Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
PNTG:US | The Pennant Group, Inc. | Common share | - | US70805E1091 | $35.69 |
Company name | The Pennant Group |
---|---|
Sector | Health Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services |
Business address | 1675 E. RIVERSIDE DRIVE, SUITE 150 EAGLE ID 83616 2089576025 |
Mailing address | 1675 E. RIVERSIDE DRIVE, SUITE 150 EAGLE ID 83616 |
Website | www.pennantgroup.com |